Clinical Research Directory
Browse clinical research sites, groups, and studies.
Immunological Follow-up After SARS CoV2 Vaccination in Kidney Transplant Recipients
Sponsor: University Hospital, Strasbourg, France
Summary
The investigators goal is to assess the vaccine response of kidney transplant patients following vaccination against SARS-CoV-2. The study population will be derived from cohorts of kidney transplant patients who have been transplanted for more than 3 months and have no contraindications to vaccination. These patients will be vaccinated as part of routine care with a CoV-2 SARS vaccine licensed in France. In this cohort, the investigators wish to study the post-vaccination humoral response by assaying neutralizing antibodies against SARS CoV-2 and the specific cellular response of SARS Cov-2 by quantiferon and in vitro lymphocyte stimulation assays.
Official title: Immunological Follow-up After COVID 19 Vaccination in Kidney Transplant Recipients
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
37
Start Date
2021-02-02
Completion Date
2024-11-01
Last Updated
2026-08-19
Healthy Volunteers
No
Conditions
Interventions
Study of the synthesis of antibodies directed against SARS
Between 5 mL and 45 mL of additional blood will be collected to study the synthesis of antibodies against CoV-2 SARS and to investigate whether specialised immune cells also show an effective response against the virus.
Locations (1)
Caillard Sophie
Strasbourg, France